See more : Prudential Financial, Inc. (PRU) Income Statement Analysis – Financial Results
Complete financial analysis of Omnimmune Holdings, Inc. (OMMH) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Omnimmune Holdings, Inc., a leading company in the Biotechnology industry within the Healthcare sector.
- Jianpu Technology Inc. (ADRs) (US47738D3098.SG) Income Statement Analysis – Financial Results
- Daiwa House Industry Co., Ltd. (DWAHY) Income Statement Analysis – Financial Results
- PT Indocement Tunggal Prakarsa Tbk (PITPF) Income Statement Analysis – Financial Results
- Prima Meat Packers, Ltd. (2281.T) Income Statement Analysis – Financial Results
- RSWM Limited (RSWM.BO) Income Statement Analysis – Financial Results
Omnimmune Holdings, Inc. (OMMH)
Industry: Biotechnology
Sector: Healthcare
About Omnimmune Holdings, Inc.
Omnimmune Holdings, Inc., through its subsidiary, Omnimmune Corp., operates as a development-stage biotechnology company integrating complementary cancer therapeutic, diagnostic, and prognostic technologies in the United States. The company owns rights for monoclonal antibody technologies. It also intends to develop personalized cancer treatment with the selection of prophylactic and therapeutic vaccines (active immunization), monoclonal antibodies (passive immunization), and genomic-based products, which target a hormone called human chorionic gonadotropin. In addition, the company plans to conduct a Phase I trial with its lead candidate anti-human chorionic gonadotropin beta subunit monoclonal antibodies based upon the results of the diagnostic trial. Omnimmune Holdings, Inc. is based in Houston, Texas.
Source: https://incomestatements.info
Category: Stock Reports